Intestinal ex vivo organoid culture reveals altered programmed crypt stem cells in patients with celiac disease

Sci Rep. 2020 Feb 26;10(1):3535. doi: 10.1038/s41598-020-60521-5.

Abstract

The ex vivo generation of gastrointestinal organoids from crypt stem cells opens up the possibility of new research approaches investigating gastrointestinal diseases. We used this technology to study differences between healthy controls and patients with celiac disease (CD). We noticed distinct dissimilarities in the phenotypes of organoids between our study groups and found considerable variations in their gene expression. Extracellular matrix genes involved in epithelial-mesenchymal transition are expressed most differently. In addition, we demonstrated epigenetic modifications that might be responsible for the different organoid gene expression thus accounting for a deranged crypt/villus axis development in CD. The organoids have proven valuable to demonstrate fundamental differences in duodenal derived organoids between healthy controls and patients with CD and thus are a suitable tool to gain new insights in pathogenesis of CD.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Celiac Disease / metabolism*
  • Celiac Disease / pathology
  • Duodenum / metabolism*
  • Duodenum / pathology
  • Epigenesis, Genetic*
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / pathology
  • Female
  • Humans
  • Intestinal Mucosa / metabolism*
  • Intestinal Mucosa / pathology
  • Male
  • Middle Aged
  • Organ Culture Techniques
  • Organoids / metabolism*
  • Organoids / pathology
  • Stem Cells / metabolism*
  • Stem Cells / pathology